Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Provides Update on Recent Business Progress
EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and nine months ended September 30, 2026 and provided an update on recent business progress. Financial Results Total Revenue: For the three and nine months ended September 30, 2026, total revenue was $83.7 million and $244.6 million, up 14% and […]
A promising new study suggests that more than half of younger adults with type 2 diabetes could achieve remission in just six months through a combination of a low-calorie diet and structured…
A promising new study suggests that more than half of younger adults with type 2 diabetes could achieve remission in just six months through a combination of a low-calorie diet and structured…
Ghosh's research focuses on developing microscopic machines that can be controlled using magnetic fields. He began working on magnetically controlled swimming robots and designed spiral-shaped…
